WEINSTOCK, G.M., David ŠMAJS, J. HARDHAM and S.J- NORRIS. From microbial genome sequence to applications. Res. Microbiol. 2000, vol. 2000, No 151, p. 151-158.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name From microbial genome sequence to applications
Authors WEINSTOCK, G.M., David ŠMAJS, J. HARDHAM and S.J- NORRIS.
Edition Res. Microbiol. 2000.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10600 1.6 Biological sciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Changed by Changed by: prof. MUDr. David Šmajs, Ph.D., učo 1116. Changed: 24/1/2003 13:14.
Abstract
Whole genome sequences of microbial pathogens present new opportunities for clinical applications. Chief among these are development of antimicrobials, diagnostics, and vaccines. While antimicrobial development is a more difficult, long-term prospect, new diagnostics and vaccines are likely to be the first products of microbial genomics. To take advantage of whole genome sequences, methods for production of gene products in surrogate hosts (heterologous expression) are required that will work for large-scale, high-throughput gene expression. This will allow genomic information from even the most experimentally difficult pathogens to be mined for applications. In addition, screening methods to test gene products for their potential as vaccine candidates are needed for large-scale screening. These areas for technological development should be stimulated by the potential for converting genomic sequence information into applications.
PrintDisplayed: 30/9/2024 23:32